Small Molecules, Generics
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
272
NCT02268045
Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma
Phase: Phase 3
Role: Collaborator
Start: May 31, 2013
Completion: Jul 31, 2017
Loading map...